Robert Stuver

635 total citations
28 papers, 99 citations indexed

About

Robert Stuver is a scholar working on Pathology and Forensic Medicine, Dermatology and Oncology. According to data from OpenAlex, Robert Stuver has authored 28 papers receiving a total of 99 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pathology and Forensic Medicine, 13 papers in Dermatology and 13 papers in Oncology. Recurrent topics in Robert Stuver's work include Lymphoma Diagnosis and Treatment (19 papers), Cutaneous lymphoproliferative disorders research (13 papers) and T-cell and Retrovirus Studies (10 papers). Robert Stuver is often cited by papers focused on Lymphoma Diagnosis and Treatment (19 papers), Cutaneous lymphoproliferative disorders research (13 papers) and T-cell and Retrovirus Studies (10 papers). Robert Stuver collaborates with scholars based in United States, Italy and Israel. Robert Stuver's co-authors include Steven M. Horwitz, Alison J. Moskowitz, Shamir Geller, Zachary D. Epstein‐Peterson, Salvia Jain, Mark Acosta, Niloufer Khan, Barbara Pro, Christian Gisselbrecht and Lauren Pinter‐Brown and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Robert Stuver

21 papers receiving 99 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Stuver United States 6 71 47 45 44 11 28 99
Steve Horwitz United States 4 41 0.6× 31 0.7× 35 0.8× 42 1.0× 18 1.6× 7 90
Sarah Noor United States 6 42 0.6× 31 0.7× 75 1.7× 32 0.7× 9 0.8× 25 119
Emily C. Ayers United States 5 33 0.5× 13 0.3× 4 0.1× 35 0.8× 11 1.0× 19 69
Jérôme Paillassa France 6 37 0.5× 23 0.5× 5 0.1× 38 0.9× 18 1.6× 20 78
Robert Twigger Australia 6 125 1.8× 79 1.7× 193 4.3× 50 1.1× 11 1.0× 8 208
Louise Roulin France 6 36 0.5× 9 0.2× 5 0.1× 47 1.1× 32 2.9× 18 90
Anne Roggy France 3 11 0.2× 20 0.4× 14 0.3× 22 0.5× 35 3.2× 4 91
S. Pandey India 4 34 0.5× 53 1.1× 2 0.0× 40 0.9× 15 1.4× 16 98
Inge Vrelust Belgium 6 11 0.2× 41 0.9× 9 0.2× 16 0.4× 18 1.6× 13 94
Dina F. El‐Essawi Egypt 5 7 0.1× 23 0.5× 45 1.0× 9 0.2× 14 1.3× 10 94

Countries citing papers authored by Robert Stuver

Since Specialization
Citations

This map shows the geographic impact of Robert Stuver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Stuver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Stuver more than expected).

Fields of papers citing papers by Robert Stuver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Stuver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Stuver. The network helps show where Robert Stuver may publish in the future.

Co-authorship network of co-authors of Robert Stuver

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Stuver. A scholar is included among the top collaborators of Robert Stuver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Stuver. Robert Stuver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Christensen, Rachel E., Robert Stuver, Stephen W. Dusza, et al.. (2025). Skin Response to Mogamulizumab in Patients With Mycosis Fungoides and Sezary Syndrome: A Retrospective, Real World Cohort. Clinical Lymphoma Myeloma & Leukemia. 25(12). e1098–e1107.e3.
2.
Pulitzer, Melissa, et al.. (2025). Diagnosis of cutaneous T-cell lymphoma following exposure to biologic agents for atopic dermatitis: A retrospective cohort study from a single tertiary cancer center. Journal of the American Academy of Dermatology. 92(6). 1394–1395. 2 indexed citations
3.
Abramson, Jeremy S., et al.. (2024). Management of peripheral neuropathy associated with brentuximab vedotin in the frontline treatment of classical Hodgkin lymphoma. Critical Reviews in Oncology/Hematology. 204. 104499–104499.
4.
Stuver, Robert, Ting Zhou, Michael Zaidinski, et al.. (2024). A Novel JAK2 Fusion in T‐Cell Prolymphocytic Leukemia. Genes Chromosomes and Cancer. 63(6). e23252–e23252.
5.
Stuver, Robert & Sarah McCue Horwitz. (2024). Through thick and thin: confronting the aggressive cutaneous T-cell lymphomas. Hematology. 2024(1). 62–68.
6.
Luttwak, Efrat, Esther Drill, Nivetha Ganesan, et al.. (2024). Brentuximab Vedotin-Based Regimens for Older Patients with Newly Diagnosed Classical Hodgkin Lymphoma - International, Multi-Center Real-World Experience. Blood. 144(Supplement 1). 1668–1668.
7.
Moskowitz, Alison J., Robert Stuver, & Steven M. Horwitz. (2024). Current and upcoming treatment approaches to common subtypes of PTCL (PTCL, NOS; ALCL; and TFHs). Blood. 144(18). 1887–1897. 7 indexed citations
8.
Horwitz, Steven M., Salvia Jain, Jacob D. Soumerai, et al.. (2024). Initial Results of a Phase 1 First-in-Human Study of Cemsidomide (CFT7455), a Novel MonoDACTM Degrader, in Patients with Non-Hodgkin's Lymphoma. Blood. 144(Supplement 1). 467–467. 4 indexed citations
9.
Stuver, Robert, Esther Drill, Nivetha Ganesan, et al.. (2023). Outcomes for Patients with Classical Hodgkin Lymphoma Who Relapse after Autologous Stem Cell Transplant in the Era of Novel Therapies. Blood. 142(Supplement 1). 3069–3069. 1 indexed citations
10.
Stuver, Robert, Steven M. Horwitz, Ranjana H. Advani, et al.. (2023). Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II–IV peripheral T‐cell lymphoma. British Journal of Haematology. 202(3). 525–529. 7 indexed citations
11.
Stuver, Robert & Alison J. Moskowitz. (2023). Therapeutic Advances in Relapsed and Refractory Peripheral T-Cell Lymphoma. Cancers. 15(3). 589–589. 9 indexed citations
12.
Stuver, Robert & Shamir Geller. (2023). Advances in the treatment of mycoses fungoides and Sézary syndrome: a narrative update in skin-directed therapies and immune-based treatments. Frontiers in Immunology. 14. 1284045–1284045. 11 indexed citations
13.
Stuver, Robert, Zachary D. Epstein‐Peterson, & Steven M. Horwitz. (2023). Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas. Haematologica. 108(12). 3244–3260. 5 indexed citations
14.
Stuver, Robert, et al.. (2023). Mycosis Fungoides and Sézary Syndrome. PubMed. 26(3). 635–646. 1 indexed citations
15.
Stuver, Robert, Steven M. Horwitz, & Zachary D. Epstein‐Peterson. (2023). Treatment of Adult T-Cell Leukemia/Lymphoma: Established Paradigms and Emerging Directions. Current Treatment Options in Oncology. 24(8). 948–964. 5 indexed citations
16.
Stuver, Robert, Stephen W. Dusza, Zachary D. Epstein‐Peterson, et al.. (2023). Cutaneous T-Cell Lymphoma and Dupilumab Use: A Retrospective Matched Cohort Study of Clinical Characteristics and Treatment Outcomes. Blood. 142(Supplement 1). 6184–6184. 1 indexed citations
17.
Stuver, Robert, Natasha Lewis, Ahmet Doǧan, & Steven M. Horwitz. (2022). Moving towards biologically informed treatment strategies for T-cell lymphomas. International Journal of Hematology. 117(4). 492–503. 2 indexed citations
18.
Koh, Min Jung, Robert Stuver, Paul Bain, et al.. (2022). Comparative efficacy and tolerability of novel agents vs chemotherapy in relapsed and refractory T-cell lymphomas: a meta-analysis. Blood Advances. 6(16). 4740–4762. 3 indexed citations
19.
20.
Stuver, Robert, et al.. (2018). Multiple Myeloma Masquerading as Ovarian Carcinosarcoma Metastases: A Case Report and Review of the Approach to Multiple Myeloma Screening and Diagnosis. SHILAP Revista de lepidopterología. 2018. 1–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steve Horwitz Breakdown of academic impact, for papers by Sarah Noor Breakdown of academic impact, for papers by Emily C. Ayers Breakdown of academic impact, for papers by Jérôme Paillassa Breakdown of academic impact, for papers by Robert Twigger Breakdown of academic impact, for papers by Louise Roulin Breakdown of academic impact, for papers by Anne Roggy Breakdown of academic impact, for papers by S. Pandey Breakdown of academic impact, for papers by Inge Vrelust Breakdown of academic impact, for papers by Dina F. El‐Essawi
Rankless by CCL
2026